Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Axiom Intelligence Acquisition Corp 1 Announces the Separate Trading of its Class A Ordinary Shares and Rights, Commencing August 1, 2025
-
Lifetime Brands Announces Second Quarter 2025 Financial Results Release Date and Conference Call
-
Hiab has closed the sale of MacGregor
-
Yellow Network Launches $YELLOW Token Sale on Republic to Power Universal Web3 Infrastructure
-
Vendasta Opens Saskatchewan’s First Corporate Childcare Partnership with Tykes & Tots
-
Oxford Square Capital Corp. Announces Offering of Notes
-
Namib Minerals Provides Corporate Update
-
Discovery Announces Senior Management Appointment
-
Nuvectis Pharma Provides Final Clinical Data Update from the NXP800 Phase 1b Study in Ovarian Cancer and Reports Completion of the NXP900 Phase 1a Dose Escalation Study
-
Lifeist’s Mikra Cellular Sciences Targets Athletes Through Strategic Partnership with the ASICS Runkeeper app and Race Roster
-
Crescent Biopharma Reports Second Quarter 2025 Financial Results and Recent Business Highlights
-
Japan Blockchain Week 2025 (Aug 22 – Sep 19) — The Perfect Window to Experience Japan’s Most Vibrant Web3 Scene
-
BriaCell Adds UCLA Health as Key Site in Pivotal Phase 3 Breast Cancer Study
-
MariMed’s Products to Enter Pennsylvania Market Through a Management Services and Licensing Agreement with TILT Holdings
-
Effective Date of Consolidation of Shares
-
DT Midstream Reports Strong Second Quarter 2025 Results
-
Repligen Announces Strategic Partnership with Novasign to Further Advance Bioprocessing Digitalization
-
Kura Oncology to Report Second Quarter 2025 Financial Results
-
Hillman Publishes Annual Corporate Responsibility Fact Sheet for 2024
-
Plus Therapeutics Provides US Launch Update for its CNSide® Diagnostic
-
Intellia Therapeutics to Hold Conference Call to Discuss Second Quarter 2025 Earnings and Company Updates
-
Global Crossing Airlines Sets Second Quarter 2025 Conference Call for August 14, 2025 at 5:00 p.m. ET
-
Dyadic International, Inc. Announces Pricing of Public Offering of 6,052,000 Shares of Common Stock
-
InflaRx to Report Second Quarter 2025 Results on August 7, 2025
-
Psyence BioMed’s Strategic Collaboration with PsyLabs Yields Breakthrough in High-Purity Ibogaine Production
-
Flow Capital Announces a C$15.0M Investment in Common Wealth
-
Anavex Life Sciences Announces Positive Precision Medicine Results from up to 4-Years of Oral Blarcamesine Treatment in Phase IIb/III Open-Label Extension Trial in Early Alzheimer’s Disease
-
ZenaTech’s ZenaDrone Initiates AUVSI Membership Upgrade, Enabling Leadership on Drone Policy and Strengthening US Defense and Government Engagement
-
Laureate Education Reports Financial Results for the Second Quarter and Six Months Ended June 30, 2025
-
Edible Garden Launches First-to-Market USDA Organic Hydroponic Basil, Reinforcing Leadership in Controlled Environment Agriculture (CEA)
-
Orrön Energy announces the sale of a 76 MW solar project in Germany
-
Former Google CEO Eric Schmidt Joins a Fireside Chat at 2025 WAIC
-
Quantum BioPharma Licensee Unbuzzd Wellness Inc. Commences Reg D Capital Raise Campaign to Fund Growth and Possible IPO
-
FOXO TECHNOLOGIES INC. ANNOUNCES LICENSE RENEWAL AND PROVIDES OPERATIONAL UPDATE FOR MYRTLE RECOVERY CENTERS, INC.
-
HII Reports Second Quarter 2025 Results
-
Build It. Style It. Show It Off. MGA’s Miniverse™ Launches Make It Mini Spaces™, The Ultimate Way to Create, Customize & Display Your Mini Worlds
-
Build It. Style It. Show It Off. MGA’s Miniverse™ Launches Make It Mini Spaces™, The Ultimate Way to Create, Customize & Display Your Mini Worlds
-
Apellis Pharmaceuticals Reports Second Quarter 2025 Financial Results
-
Gilat to Present at the 28th Annual Oppenheimer Technology, Internet & Communications Virtual Conference on Monday, August 11
-
Gilat to Present at the 28th Annual Oppenheimer Technology, Internet & Communications Virtual Conference on Monday, August 11
-
Arcadia Announces Commitments to Support the CMS-Aligned Network Strategy
-
Pasithea Therapeutics Completes Enrollment and Initial Dosing of First Cohort from its Phase 1/1b Clinical Trial of PAS-004 in Adult NF1 Patients
-
Allegro MicroSystems Reports First Quarter 2026 Results
-
Electra Begins Testing North American Feedstock for Cobalt Refinery
-
BioCryst Announces Charlie Gayer to Succeed Jon Stonehouse as Chief Executive Officer Upon his Retirement in December
-
Commerce Announces Second Quarter 2025 Financial Results
-
ISC Extends Credit Facility
-
Voluntary TSX delisting application
-
Cartier Provides Update on its Chorrillos Project, Southern Bolivia
-
Amicus Therapeutics Announces Second Quarter 2025 Financial Results and Corporate Updates
